Loading clinical trials...
Loading clinical trials...
To evaluate the safety, tolerability, and efficacy of milnacipran when taken with another drug called pregabalin in people with fibromyalgia.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Forest Laboratories
NCT07226648 · Fibromyalgia
NCT07358754 · Fibromyalgia
NCT05901259 · Cerebral Palsy, Multiple Sclerosis, and more
NCT03759522 · Fibromyalgia, Chronic Fatigue Syndrome, and more
NCT07398417 · Fibromyalgia
Forest Investigative Site
Birmingham, Alabama
Forest Investigative Site
Mesa, Arizona
Forest Investigative Site
Peoria, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions